Translational Medicine Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Physiology (Bethesda). 2020 May 1;35(3):185-195. doi: 10.1152/physiol.00030.2019.
Intermittent fasting (IF) is a widely practiced dietary method that encompasses periodic restriction of food consumption. Due to its protective benefits against metabolic diseases, aging, and cardiovascular and neurodegenerative diseases, IF continues to gain attention as a preventative and therapeutic intervention to counteract these chronic diseases. Although numerous animal studies have reported positive health benefits of IF, its feasibility and efficacy in clinical settings remain controversial. Importantly, since dietary interventions such as IF have systemic effects, thoroughly investigating the tissue-specific changes in animal models is crucial to identify IF's mechanism and evaluate its potential adverse effects in humans. As such, we will review and compare the outcomes and underlying mechanisms of IF in both animal and human studies. Moreover, the limitations of IF and inconsistencies between preclinical and clinical studies will be discussed to provide insight into the gaps between translating research from bench to bedside.
间歇性禁食(IF)是一种广泛实践的饮食方法,包括周期性限制食物摄入。由于 IF 对代谢性疾病、衰老以及心血管和神经退行性疾病具有保护作用,因此它作为一种预防和治疗干预措施来对抗这些慢性疾病的关注度不断提高。尽管许多动物研究报告了 IF 的积极健康益处,但 IF 在临床环境中的可行性和疗效仍存在争议。重要的是,由于 IF 等饮食干预措施具有全身性影响,因此在动物模型中彻底研究组织特异性变化对于确定 IF 的机制以及评估其对人类的潜在不良影响至关重要。因此,我们将综述和比较 IF 在动物和人类研究中的结果和潜在机制。此外,还将讨论 IF 的局限性以及临床前和临床研究之间的不一致性,以深入了解将研究从实验室转化到临床的差距。